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Hepatitis C virus (HCV) shows substantial nucleotide 
sequence diversity distributed throughout he viral 
genome, with many variants showing only 68 to 79 % 
overall sequence similarity to one another. Phylogenetic 
analysis ofnucleofide sequences derived from part of the 
gene encoding a non-structural protein (NS-5) has 
provided evidence for six major genotypes of HCV 
amongst a worldwide collection of 76 samples from 
HCV-infected blood donors and patients with chronic 
hepatitis. Many of these HCV types comprised a number 
of more closely related subtypes, leading to a current 
total of 11 genetically distinct viral populations. Phylo- 
genetic analysis of other regions of the viral genome 
produced relationships between published sequences 
equivalent to those found in NS-5, apart from the more 
highly conserved 5' non-coding region in which only the 
six major HCV types, but not subtypes, could be 
differentiated. A new nomenclature for HCV variants is 
proposed in this communication that reflects the two- 
tiered nature of sequence differences b tween different 
viral isolates. The scheme classifies all known HCV 
variants to date, and describes criteria that would enable 
new variants to be assigned within the classification as 
they are discovered. 
Introduction 
Infection with hepatitis C virus (HCV) has been identified 
as the major cause of post-tranfusion on-A, non-B 
hepatitis (Choo et al., 1989; Kuo et al., 1989). The virus 
has a positive-sense, ssRNA genome approximately 
10 kb in length, with similarities in genome organization 
and some sequence homology with pestiviruses and 
flaviviruses (Choo et al., 1991 ; Han et al., 1991 ; Brown 
et al., 1992). Different isolates of HCV show substantial 
nucleotide sequence variability distributed throughout 
the viral genome (Okamoto et al., 1991, 1992b). Regions 
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The nucleotide sequences obtained in this investigation have been 
submitted to GenBank and assigned the accession nmnbers L23435 to 
L23475. 
encoding the putative envelope protiens [El, E2/non- 
structural protein 1 (NS-1)] are the most variable 
(Weiner et al., 1991 ; Hijikata et al., 1991), whereas the 5'
non-coding region (5' NCR) is the most conserved (Han 
et al., 1991 ; Cha et al., 1991 ; Okamoto et al., 1990; Bukh 
et al., 1992a). Comparison of published sequences of 
HCV has led to the identification of a number of distinct 
virus' types', that may differ from each other by as much 
as 33 % over the whole viral genome (Choo et aI., 1991 ; 
Okamoto et al., 1991; Chan et al., 1992; Mori et al., 
1992; Okamoto et al., 1992b). 
This degree of sequence variability is sufficient to alter 
the antigenic and biological properties of members of 
this virus group significantly. The immunoreactive region 
of the NS-4 protein is highly variable so that most 
epitopes are type-specific (Simmonds et al., 1993b). This 
leads to a substantial reduction in the effectiveness of 
antibody assays based on this protein for serological 
diagnosis of infection with divergent HCV types (Chan et 
al., 1991; McOmish et al., 1993; Kato et al., 1991; Cha 
et al., 1992); however, second generation assays con- 
taining multiple antigens are more broadly reactive. 
Samples found positive by second generation assays, but 
negative with first generation assays, have proved to be 
new viral types (Cha et al., 1992). Whether or not other 
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2392 P. Simmonds and others 
HCV variants remain undetected using the extensive 
battery of antigens currently employed remains an area 
of intensive investigation. 
Variability in the envelope region is even greater so 
that neutralizing antibodies might be type-specific and 
allow multiple infection with different HCV variants in 
re-exposed individuals. Finally, there is some evidence 
for variation in the course of infection associated with 
different HCV variants and in response to treatment with 
interferon (Kanai et al., 1992; Yoshioka et al., 1992; 
Takada et al., 1992a; Pozzato et al., 1991). If these 
results are confirmed in larger studies this would indicate 
an important role for identification of genotype in the 
pretreatment assessment of patients with chronic hepa- 
titis. 
We have previously carried out phylogenetic analyses 
of nucleotide sequences amplified in the region of the 
genome ncoding the core protein, and parts of the NS- 
3 and NS-5 proteins (Chan et al., 1992). Although 
different degrees of variability were found in various 
parts of the genome, analysis of each produced trees 
topologically identical to those obtained upon analysis of 
complete genome sequences. Based on these initial 
results, we proposed that HCV might usefully be 
classified into three major HCV types, with variants 
designated type 1 and type 2 each comprising two more 
closely related subtypes (Chan et al., 1992). 
In this communication we have carried out phylo- 
genetic analysis of a 222 bp fragment of NS-5 between 
nucleotide positions 7975 and 8196 (numbered as in 
Choo et al., 1991). This region was amplified from 
plasma or serum of 41 infected individuals using 
relatively well conserved primers (Enomoto et al., 1990), 
and compared with 35 published NS-5 sequences from 
other laboratories. 
Methods 
Samples.  Plasma or serum samples were obtained from 41 HCV- 
infected blood donors or NANBH patients from a variety of 
geographical regions (Table 1). Sequences obtained in this study were 
compared with 35 previously published sequences listed in Table 1. 
Nucleot ide sequence analysis. To obtain sequences in the NS-5 
region, viral RNA was reverse transcribed and amplified in a single 
reaction using primers thought to be highly conserved amongst 
different variants of HCV (Enomoto et al., 1990). For some sequences, 
a second PCR was carried out with primers 554 and 555 (Chan et al., 
1992) in combination with two new primers, 122 (sense orientation; 
5" CTC AAC CGT CAC TGA GAG AGA CAT 3') and 123 (anti- 
sense; 5' GCT CTC AGG TTC CGC TCG TCC TCC 3"). Product 
DNA was phosphorylated, purified and cloned into the SmaI  site of 
pUC19 (Yanisch-Perron et al., 1985) following the procedures 
described elsewhere (Simmonds & Chan, 1993). Alternatively, amplified 
DNA was purified and directly sequenced as previously described 
(Simmonds et al., 1990; Cha et al., 1992). These methods allowed 
comparison of a 222 bp fragment of DNA homologous to positions 
7975 to 8196 in the prototype virus (numbered as in Choo et al., 1991). 
Table 1. Origin of  HC V variants analysed in this study 
No. Name Origin Reference 
1 HCV-1 U.S.A. (Choo et al., 1991) 
2 GM2 Germany This paper 
3 I21 Italy This paper 
4 SP2 Spain This paper 
5 US17 U.S.A. This paper 
6 HCV-H U.S.A. (Inchauspe t al.o 1991) 
7 PT-1 Japan (Enomoto et al., 1990) 
8 H77 U.S.A. (Ogata et al., 1991) 
9 H90 U.S.A. (Ogata et al., 1991) 
10 T1801 Scotland This paper 
11 T1825 Scotland This paper 
12 T2138 Scotland This paper 
13 GH6 Germany This paper 
14 JH Japan (Kubo et al., 1989) 
15 SP1 Spain This paper 
16 SP3 Spain This paper 
17 HCV-J Japan (Kato et al., 1990) 
18 HCV-BK Japan (Takamizawa et al., 1991) 
19 T Taiwan (Chen et al., 1992) 
20 K1 Japan (Enomoto et al., 1990) 
21 KI-1 Japan (Enomoto et al., 1990) 
22 K1-2 Japan (Enomoto et al., 1990) 
23 K1-3 Japan (Enomoto et al., 1990) 
24 K1-4 Japan (Enomoto et al., 1990) 
25 J-121 Japan This paper 
26 HPCGENOM China (Bi et al., GenBank 
number L02836) 
27 HPCJTA Japan (Tanaka et al., 1992) 
28 HPCJTB Japan (Tanaka et al., 1992) 
29 J483 Japan (Okamoto et al., 1992a) 
30 J491 Japan (Okamoto et al., 1992a) 
31 HCVJKIG ?? (Honda et al., GenBank 
number X61596) 
32 2TY4 Lebanon This paper 
33 4TY4 Lebanon This paper 
34 K2A Japan (Enomoto et al., 1990) 
35 SAC640 U.S.A. This paper 
36 HC-J6 Japan (Okamoto et al., 1991) 
37 K2A-1 Japan (Enomoto et al., 1990) 
38 T351 Scotland This paper 
39 T104 Scotland This paper 
40 FC71921 U.S.A. This paper 
41 GC167999 U.S.A. This paper 
42 GC54004 U.S.A. This paper 
43 K2B Japan (Enomoto et al., 1990) 
44 LQ41461 U.S.A. This paper 
45 K2B-1 Japan (Enomoto et al., 1990) 
46 T59 Scotland (Chan et al., 1992) 
47 T903 Scotland This paper 
48 TS10 Scotland This paper 
49 HC-J8 Japan (Okamoto et al., 1992b) 
50 ARG6 Argentina This paper 
51 ARG8 Argentina This paper 
52 I10 Italy This paper 
53 T983 Scotland This paper 
54 GH8 Germany This paper 
55 GJ61326 U.S.A. This paper 
56 I11 Italy This paper 
57 I4 Italy This paper 
58 $21 Sweden This paper 
59 T1 Thailand (Mori et al., 1992) 
60 T7 Thailand (Mori et al., 1992) 
61 Eb-1 Scotland (Chan et al., 1992) 
62 Eb-2 Scotland (Chan et al., 1992) 
63 Eb-3 Scotland (Chan et al., 1992) 
64 Eb-7 Scotland (Chan et al., 1992) 
65 T90 Scotland This paper 
Table 1. (cont.) 
No. Name Origin Reference 
66 T1787 Scotland This paper 
67 T9 Thailand (Mori et al., 1992) 
68 T10 Thailand (Mori et al., 1992) 
69 EG-7 Egypt This paper 
70 EG-13 Egypt This paper 
71 EG-19 Egypt This paper 
72 SA156 South Africa This paper 
73 SA183 South Africa This paper 
74 SA30 South Africa This paper 
75 34REV South Africa This paper 
76 HK-2 Hong Kong This paper 
Nucleotide sequence comparisons. Nucleotide sequences were aligned 
using the CLUSTAL V program (Higgins et al., 1992) as implemented 
in the GDE sequence analysis package. Distances between pairs of 
sequences were estimated using the DNADIST program of the 
PHYLIP package (version 3.4) kindly provided by Dr J. Felsenstein 
(Felsenstein, 1991), using a model which allows different rates of 
transition and transversion and different frequencies of the four 
nucleotides (Felsenstein, 1991). Phylogenetic trees were constructed 
using the neighbour-joining algorithm on the previous ets of pairwise 
distances (Saitou & Nai, 1987) using the PHYLIP program, 
NEIGHBOR. Equivalent phylogenetic relationships were also found in 
a maximum likelihood analysis (PHYLIP program DNAML; data not 
shown), and 2000 bootstrap replicates of neighbour-joining trees 
(PHYLIP programs SEQBOOT and CONSENSE). 
Results and Discussion 
Phylogenetic analysis of  NS-5 sequences 
RNA was extracted from 41 serum or plasma samples 
from a wide range of HCV-infected individuals from 
several locations (U.S.A., Europe, South America, South 
Africa, Middle East and Far East; Table 1), and 
amplified using previously published NS-5-specific 
primers (Enomoto et al., 1990). The region was chosen 
for phylogenetic analysis because it is sufficiently variable 
to allow differentiation between different isolates of 
HCV, and there is already alarge amount of comparative 
sequence data; 35 further sequences have been published 
by other groups and were included in the analysis 
described here. 
Pairwise comparisons revealed a wide range of 
evolutionary distances amongst he 76 HCV variants 
analysed. Using Felsenstein's model of molecular evol- 
ution (Felsenstein, 1991), distances ranged from 0.01 
(between T9 and T10; Mori et al., 1992) to 0"85 (EG-7 to 
K-2a; Simmonds et al., 1993a; Enomoto et al., 1990). 
However, the distribution of distances was confined to 
three separate and non-overlapping groups (Fig. 1 a). 
The first ranged from 0.38 to 0.84 (mean 0-543), the 
second showed intermediate evolutionary distances of 
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0'16 to 0"32 (mean 0.248) and the third showed arange of 
0 to 0.12 (mean of 0.061). In none of the 2850 pairwise 
comparisons were distances of 0.14 to 0" 16 or 0.34 to 0-38 
found. Furthermore, in no case did the mean value of 
each distribution _+3 S.D. overlap with any other, 
indicating that at least 99.7 % of evolutionary distances 
would be expected to fall within these non-overlapping 
ranges. 
Three levels of sequence diversity may also be observed 
in a phylogenetic tree of NS-5 sequences (Fig. 2). This 
analysis hows six major groupings of sequences that are 
approximately equally divergent from each other. Within 
some of the major groupings, two or three clusters of 
more closely related variants are observed. 
Mean evolutionary distances between variants in 
different major branches ranged from 0.41 to 0.66 (Table 
2), and distances between the different clusters within the 
major branches were in all cases ubstantially ower (0.20 
to 0-30). Using the grouping of sequences suggested by 
Fig. 2, the distribution of mean differences (Table 2) lies 
entirely within the overall distribution of distances 
derived from pairwise comparison of individual 
sequences (Fig. 1). 
Based on these results, we propose a classification of 
HCV that incorporates the three clearly distinct levels of 
HCV sequence variability. In this scheme, the major 
groupings of sequence variants are designated HCV 
' types', whereas the more closely related groups observed 
within some types are termed 'subtypes'. In Fig. 2, we 
have labelled the HCV types in Arabic numbers, and the 
subtypes by lower case letters, in order of discovery. 
Thus the genotype of the variant, HCV-1, first cloned by 
Choo et al. (1991) is assigned as type la (sequence no. 1). 
In this comparison, we have included fragments from 
a number of other complete genomic sequences. HCV-H 
(no. 6) shows 95.4 % nucleotide sequence identity with 
HCV-1 over the length of the genome, and is also 
classified as type la in this scheme. Several of the more 
divergent Japanese and Taiwanese sequences (e.g. HCV- 
BK, HCV-J and T; nos. 17, 18 and 19) that show 78 to 
79 % overall sequence similarity with HCV-1 fall into a 
separate phylogenetic group labelled type lb in Fig. 2. 
The most divergent complete genomic sequences HC-J6 
and HC-J8 (nos. 36 and 49) that show only 67.1 to 68-3 % 
sequence similarity with types la and lb cluster in 
separate groups, and have been designated types 2a and 
2b respectively. 
The group labelled 3a contains NS-5 sequences from 
variants from Scottish blood donors previously described 
as type 3 (nos. 61, 62, 63 and 64; Chan et al., 1992), and 
variants found in NANBH patients from Thailand 
described by the authors as type V (nos. 59 and 60; Mori 
et al., 1992). Our phylogenetic analysis of further variants 
from Thailand originally termed type VI (nos. 67 and 68) 
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Fig. 1. Distribution of evolutionary distances (a) and percentage 
sequence similarities (b) upon pairwise comparison of 76 nucleotide 
sequences of HCY variants in the NS-5 region (2850 comparisons). (a)
Number of calculated evolutionary distance measurements (in incre- 
ments of 0.02) from 0.00 to 0.86 recorded on the y-axis. (b) Number 
of observed sequence similarities (in increments of 1%) recorded on the 
y-axis. Mean + 3 S.D. for each distribution shown by horizontal bar. 
indicated that they were a further subtype of type 3 
rather than a major new HCV type. 
The six groups, la, lb, 2a, 2b, 3a and 3b, account for 
all of the previously published NS-5 sequences of HCV 
and the majority of those obtained in this study. 
However, from Fig. 2 we can provisionally assign the 
remainder of the sequences as new types and subtypes of 
HCV. Sequences amplified from Lebanese NANBH 
patients (nos. 32 and 33) correspond to a further subtype 
of type 1, and sequences from NANBH patients in 
Argentina nd Italy, and a Scottish blood donor (nos. 50 
to 53) cluster together as a new subtype of type 2. 
Variants in the group labelled 4a re all from Egypt. 
Their status as a new genotype is consistent with our 
previous analysis of sequences in the core region from 
these blood donors, where we found that they grouped 
separately from those of types 1, 2 and 3 (Simmonds et 
al., 1993a). The group labelled 5a contains variants 
previously designated as group V on the basis of previous 
sequence analysis of the 5' NCR and NS-5 regions (Cha 
et al., 1992). The sequence labelled type 6a (no. 76) was 
obtained from a Hong Kong blood donor. This variant 
also differs from all other HCV sequences in the 5' NCR 
by the presence of a unique 2 bp insertion at position 
-143  (Simmonds et al., 1993a). Sequences elsewhere in 
the genome have yet to be examined. 
Comparison of the nomenclature shown in Fig. 2 with 
those originating from other laboratories reveals both 
similarities and differences (Table 3). Alternative class- 
ifications have identified the existence of distinct geno- 
types, but often do not recognize the two-tiered range of 
sequence differences. For example, a scheme described 
by Okamoto et al. (1991, 1992b) and Mori et al. (1992) 
describes HCV types I, II, III, IV, V and VI which 
correspond to types la, lb, 2a, 3a and 3b respectively. 
Cha et al. (1992) described five groups of HCV variants, 
where I corresponds to la, II to lb, III to 2a, 2b and 2c, 
IV to 3a and 3b to V to type 5a. Consequently, these 
classifications are difficult to extend to incorporate type 
lc, 2c and possibly other new subtypes as they are 
discovered. Differences between the various schemes 
have contributed to many of the difficulties in comparing 
results from different research centres. 
Identification of  HCV variants 
The largest collections of comparative sequence data are 
currently in the NS-5 region analysed here and in the 5' 
NCR. The NS-5 region is a useful region for virus 
identification because it may be amplified readily from 
plasma or serum of infected individuals using published 
primer sequences (Enomoto et al., 1990), and because it 
is sufficiently variable that both types and subtypes may 
be identified. Although in principle other parts of the 
coding region of the viral genome may be equally 
informative, the current lack of comparative sequence 
would prevent comparison with the newer sequence 
variants (types 4 to 6). 
Phylogenetic analysis provides the most accurate 
reconstruction of evolutionary relationships and dis- 
tances between HCV sequences. However this approach 
is computationally intensive, and it is easier simply to 
calculate the proportion of matched nucleotides upon 
each pairwise comparison of sequences. These (uncor- 
rected) sequence similarities do not allow for multiple 
substitutions and can greatly underestimate the true 
extent of divergence between dissimilar sequences (Fig. 
1 b). Sequence similarities between different isolates of 
the same HCV type (88 to 100%) closely match 
corresponding evolutionary distances (0 to 0.12), whereas 
those between subtypes (74 to 86 %) and between types 
(56 to 72%; Fig. l b) differ substantially from the 
Hepatitis C virus." six major genotypes 2395 
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Fig. 2. Phylogenetic analysis of NS-5 sequences 
from 76 isolates of HCV, showing six major HCV 
types and subsidiary groupings within some HCV 
types. Sequences numbered as in Table 1. 
Tab le  2. Mean evolutionary distances between phylogenetic groupings* 
HCV 
type-~ n:~ la lb lc 2a 2b 2c 3a 3b 4a 5a 6a 
la 
lb 
lc 
2a 
2b 
2c 
3a 
3b 
4a 
5a 
6a 
12 0.0461 
19 0.2413 0.0634 
2 0.1958 0.3017 0.0465 
6 0.6263 0.6026 0"5374 0.0878 
10 0.5659 0.5177 0.4935 0.2519 0.0719 
4 0.6118 0.6022 0.5825 0.2305 0.2577 0.0892 
13 0.4926 0'5068 0.5422 0.6392 0.5579 0.6336 0.0532 
2 0.5042 0.4207 0.4478 0.6082 0.5079 0.6293 0.2742 0.0091 
3 0.5185 0.5967 0.5445 0.6583 0.6154 0.6354 0.5347 0.4578 0.1354 
4 0.4535 0.4293 0.4453 0.5502 0.5003 0.6072 0.5132 0.4479 0.5487 0.0432 
1 0.5765 0.5289 0.6255 0.5641 0.5388 0.5732 0.5638 0.6234 0.5238 0.4974 NA§ 
* Distances between subtypes underlined, distances between isolates in bold. 
I" Groupings derived by phylogenetic analysis of NS-5 sequences (see Fig. 2). 
:~ Number of sequences compared within each group. 
§ NA, Not applicable. 
equ iva lent  ranges  for  evo lu t ionary  d is tances  (0.16 to 0.34 
and  0.38 to 0"86; Fig. la ) .  However ,  even  these 
uncor rected  d is tances  produce  three  non-over lapp ing  
(a l though compressed)  d i s t r ibut ions  that  exact ly  re- 
p roduce  the type /subtype  d is t inc t ion  der ived f rom 
evo lu t ionary  analys is .  
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Table  3. Compar ison  o f  nomenc lature  fo r  HCV types* 
Proposed Sequence Published Chan/ Mori/ Tsukiyama- 
name numberst example Cha Simmonds Enomoto Okamoto Kohara 
la 1 12 HCV-1,-H I la K-PT I NC:~ 
lb 13-31 HCV-J, -BK II lb K-1 II I 
lc 32, 33 - -  NC NC YC NC NC 
2a 34~39 HC-J6 III 2a K-2a Ill II 
2b 40~49 HC-J8 III 2b K-2b IV II 
2c 50-53 III Nc NC NC NC 
3a 54-66 Ta, E-bl IV 3 NC V NC 
3b 67, 68 Tb IV NC NC VI NC 
4a 69 71 - -  NC 4 NC NC NC 
5a 72-75 - -  V NC NC NC NC 
6a 76 NC YC NC NC NC 
* Proposed nomenclature for published HCV sequences and comparison with existing schemes Cha: Cha et al. 
(1992); Chan/Simmonds: Chan et aL (1992); Simmonds et al. (1993a); Enomoto: Enomoto et al. (1990); 
Mori/Okamoto: Okamoto et al. (1992b); Mori et aL (1992); Tsukiyama-Kohara: Tsukiyama Kohara et al. 
(1991). 
-~ Sequences numbered as in Table 1. 
:~ NC, Sequences not classified by originating authors. 
7975 803O 8085 
la  ATcTACCAaTGTTGTGAcCTgGACCCCCAAGCCCGcgtGGCCATCAaGTCCCTCACtGAGAGGCTTTAtGTtGGGGGCCCtCTTACcAAtTCaAGgGGGGAaAACTGCGGC 
b . . t . . *  * . *  . . . .  * .T . . .C* . . .G .* . . *A*aCa* .** . .A .g* . .G  . . . . .  a . . .C . * . . * . . *a .C  . . . . .  t .~c* .G . . t . . t . . * .Aa%. .C .G  . . . . .  t 
c , . .A . . *  . . . . . . . . . . . . . . .  C . . . . .  G .C . .A  . . . .  cT  . . . . . . . .  AAAT . . . . . . . . . . .  AT .G . .C . .C . .a . .G . .C* .G . . *  . . . . . . .  Aa . .C . . *  , 
2a  . .A . . * . *gGC* . .cTC.* . *cC*GAGG.G. . t . * .AcT  . . . . .  AC .C . .g . .G .  . a . . c . .C . .G . .A . .G . .cA .GcT* . .CAGc°A. . .CC .g .C  . . . . . .  g 
b . .A . .T . .GGC* . . *TC* . . .CCt*AaG.g . . *A*AACT.** . .aC .C . .g .  * . . . .  A . . c . .C . .a . .a . .G . .CA .G.*a . .CAGC.Aa . . *C . .TC*  . . . . .  t 
c ~. .  * *G*Cc  *TCA. . .CCtgAGG.G. . t . .aACT. . t . .AC .C . .A* .G  . . . . . . . .  a . .a . .C . .a . . * . .G . .CA .G. .A . .CAGC.Aa . . *C .*TC . . . . . .  g ,  
3a  I . .A . . * . . * . . c . . .a . * . . t . .a . *GG.G. . .A .gAaa .TG. . *TCC.  .G . . *C  . . . .  CTGC. . *  . . . . .  *A .GTt . . . cAGc .A*  . . . .  cCC.g . . t . .T  
b , . .A  . . . . . . . .  C . . . . . . . .  T . .G . .AG.G. .T . .GAA. . .G  . . . .  GCG.T  . . . . .  A . . .C  . . . .  G . .CA .C . .A . .T . .CA .GTA. . .CAGT°A . . . .  CTCC.G . . . . . .  , 
4a  ,G  . . . .  T . .G  . . . . . .  a**  . . . . .  G .* .G .* . . t . . .AA . . tT . .T*CTG . . . . . . .  a . .A . .A . *C* .c . *G. .C  . . . . .  CA .GCA. . . cAGC.A . . .A . .CCTT . .T . .G  
5a  . . t  . . . . . . .  CA  . . . . . .  T . .C .G . .TG.G.*g . . * . * . . .A . .ACG. . .A  . . . . .  CC .AC.C . .G . .CTG. . .A  . . . . .  *A .GTAT. .CAGC.A  . . . .  C . .C .A .* t **T  
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Fig. 3. Comparison of consensus nucleotide sequences ofpart of NS-5 from HCV types 1 to 6. Numbers of sequences assigned to each 
type and subtype are shown in Table 2. Lower case letters indicate variable siteswithin sequence group, majority nucleotide shown. 
Where no nucleotide forms a majority, IUPAC ambiguity codes are used: 'y', C or T; 'v', G, C or A; 'w', T or A. Other symbols: 
dots (.), identity with type 1 a sequence; hyphens represent gap introduced to preserve sequence alignment ( ype 6a); asterisks represent 
variable nucleotide positions where majority sequence is the same as type la. Sequences numbered as in Choo et al. (1991). 
The  consensus  sequences  o f  each type and  subtype  
descr ibed in this paper  (Fig. 3) represent  an 'average '  
sequence for  each HCV group  and may be conven ient ly  
used for  the ident i f icat ion and  prov is iona l  c lassi f icat ion 
o f  new HCV var iants .  Sequence  simi lar it ies o f  less than  
72 % wi th  any o f  the 11 consensus  nuc leot ide  sequences  
ind icate  that  the new sequence shou ld  be des ignated  a 
new HCV type. Those  showing  sequence similar it ies o f  
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between 75 % and 86 % with particular variants and less 
than 72% with other should be assigned as a new 
subtype. Clearly, if the new sequence showed greater 
than 88 % similarity with any of the consensus sequences 
in Fig. 3, then it should not be assigned a new type 
description. It should be stressed that this type of 
classification must be regarded as provisional, and a 
more complete analysis of evolutionary relationships by 
phylogeny would be required to confirm sequence 
designations. 
Sequence comparisons in other regions of  the genome 
We have carried out comparable analysis in the core 
region using sequences of HCV types 1 to 4 (Simmonds 
et al., 1993a). This region also produces three non- 
overlapping distributions of sequence similarities, al- 
though in this case, different HCV types show much 
greater similarities than for NS-5 (data not shown). 
Using the region of core shown in our previous analysis 
and sequences listed therein (positions 29 to 269; 
Simmonds et al., 1993 a), we found similarities between 
HCV types ranged from 81 to 89% whereas those 
between subtypes were from 91 to 94%. Sequence 
similarities of greater than 94% are found between 
different isolates of the same HCV type. 
All of the six major types of HCV may also be 
identified by comparison of sequences in the 5' NCR 
(Simmonds et al., 1993a; Bukh et al., 1992b; Cha et al., 
1992), although often only relatively few nucleotide 
differences exist between them. Nucleotide sequence 
variability in the 5' NCR also differs from that found in 
the coding regions in that there are no reliable sequence 
polymorphisms in this region that allow the differenti- 
ation of HCV subtypes. HCV types la, lb and lc show 
essentially the same sequences in the 5' NCR, as do types 
2a and 2c (Chan et al., 1992; Cha et al., 1992; Simmonds 
et al., 1993a). At this stage, it appears that reliable 
differentiation i to subtypes will remain dependent on 
analysis of coding regions. 
Origins of  HCV types 
The samples used in this study were from either blood 
donors or patients with non-A, non-B hepatitis. Al- 
though a comprehensive geographical survey of HCV 
types was not attempted, there do appear to be 
differences in their distribution in different countries. 
HCV types 1 and 2 have been found in almost all 
countries tested, including those in Europe, North 
America and the Far East (Li et al., 1991 ; Takada et al., 
1992a, b; Cha et al., 1992; Kato et al., 1991 ;Chan et aI., 
1992). Although HCV type 3 has not been found in 
Japan, it has been frequently reported from Europe 
(Chan et al., 1992), U.S.A. (Lee et al., 1992), Thailand 
(Mori et al., 1992) and India (unpublished observations). 
In the Middle East, almost all anti-HCV-positive 
individuals identified on blood donor screening are 
infected with type 4 (Simmonds et al., 1993 a), which has 
also been detected in NANBH patients in Zaire (Bukh et 
al., 1992b). HCV types 5 and 6 show highly restricted 
geographical distributions, being apparently confined to 
South Africa and Hong Kong respectively (Cha et al., 
1992; Simmonds et al., 1993a). At this stage it is difficult 
to interpret the significance of these different distri- 
butions of variants, as the epidemiology of virus spread 
is at present poorly understood. 
In summary, we have used a series of comparative 
methods to establish sequence relationships between 
HCV variants. The system is internally consistent, and 
the phylogenetic and numerical comparison methods 
described here will facilitate the assigment of new 
sequence variants as they are discovered. The uniform 
nomenclature proposed in Table 2 would, if adopted, 
considerably clarify comparative valuation of results 
from different laboratories. This requirement will un- 
doubtedly increase as more is understood about the 
important biological and serological differences that 
have been found to exist between the different variants of 
HCV. 
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